Keyword Index

A

  • ACT and FOX genes The role of ACT and FOX genes in Klebsiella pneumoniae strains isolated from hospitalized patients [Volume 1, Issue 2, 2022, Pages 18-25]
  • Adrenergic uptake Therapeutic potentials of reserpine formulations: Recent progress and challenges [Volume 2, Issue 2, 2023, Pages 1-5]
  • Aedes aegypti Larvicidal activities of local bacteria against Aedes aegypti larvae [Volume 2, Issue 2, 2023, Pages 34-41]
  • Alkyl chains Novel formulations of alginate and its derivatives in microbial infections, biomedical implants, and cancers [Volume 3, Issue 1, 2024, Pages 35-40]
  • Alpha tocopherol Main distinctions between tocosome and nano-liposome as drug delivery systems: A scientific and technical point of view [Volume 2, Issue 1, 2023, Pages 26-29]
  • Alzheimer's disease Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms [Volume 2, Issue 1, 2023, Pages 1-7]
  • AmpC enzymes The role of ACT and FOX genes in Klebsiella pneumoniae strains isolated from hospitalized patients [Volume 1, Issue 2, 2022, Pages 18-25]
  • Amphiphilic alginate Novel formulations of alginate and its derivatives in microbial infections, biomedical implants, and cancers [Volume 3, Issue 1, 2024, Pages 35-40]
  • Anti-acidogenic Anticancer, antimicrobial, anti-inflammatory, and neuroprotective effects of bisdemethoxycurcumin: Micro and nano facets [Volume 2, Issue 4, 2023, Pages 17-24]
  • Antibacterial activities Modification of silica nanoparticles for antibacterial activities: mechanism of action [Volume 1, Issue 1, 2022, Pages 49-58]
  • Antibacterial Activity Antibacterial, antiviral, and antifungal activities of quinine and its derivatives: A narrative mini-review [Volume 2, Issue 3, 2023, Pages 1-6]
  • Antibacterial agents Synergistic combinations of metal, metal oxide, or metalloid nanoparticles plus antibiotics against resistant and non-resistant bacteria [Volume 1, Issue 1, 2022, Pages 1-9]
  • Antibacterial mechanisms Interaction of copper oxide nanoparticles with bacterial nucleic acids: a mini-review [Volume 2, Issue 1, 2023, Pages 20-25]
  • Antibiotic-Resistant A review on antifungal and antibacterial activities of some medicinal plants [Volume 1, Issue 1, 2022, Pages 10-17]
  • Anticancer Therapeutic aspects of genistein based on recent advances and challenges [Volume 2, Issue 2, 2023, Pages 6-12]
  • Anticancer Anti-neurodegenerative, anticancer, anti-inflammatory, and antiobesity activities of theaflavin and its derivatives [Volume 2, Issue 4, 2023, Pages 8-16]
  • Anti-cataract potential Antioxidant, antineurodegenerative, anticancer, and antimicrobial activities of caffeine and its derivatives: micro and nano aspects [Volume 2, Issue 3, 2023, Pages 32-37]
  • Anticholinergic activity Anticholinergic, antimicrobial, and anticancer perspectives of atropine: a mini-review [Volume 2, Issue 1, 2023, Pages 39-44]
  • Antidiabetic Therapeutic aspects of genistein based on recent advances and challenges [Volume 2, Issue 2, 2023, Pages 6-12]
  • Antifungal activity Antibacterial, antiviral, and antifungal activities of quinine and its derivatives: A narrative mini-review [Volume 2, Issue 3, 2023, Pages 1-6]
  • Antihyperlipidemic activity Therapeutic applications of apigenin and its derivatives: micro and nano aspects [Volume 2, Issue 1, 2023, Pages 30-38]
  • Antimicrobial Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms [Volume 2, Issue 1, 2023, Pages 1-7]
  • Antineoplastic Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms [Volume 2, Issue 1, 2023, Pages 1-7]
  • Anti-neurodegenerative Anti-neurodegenerative, anticancer, anti-inflammatory, and antiobesity activities of theaflavin and its derivatives [Volume 2, Issue 4, 2023, Pages 8-16]
  • Antiobesity Anti-neurodegenerative, anticancer, anti-inflammatory, and antiobesity activities of theaflavin and its derivatives [Volume 2, Issue 4, 2023, Pages 8-16]
  • Anti-osteoporosis effect Formulations of galangin and its derivatives with antimicrobial, anticancer, and anti-neurodegenerative effects: Recent advances and challenges [Volume 2, Issue 4, 2023, Pages 41-46]
  • Antiviral Therapeutic aspects of genistein based on recent advances and challenges [Volume 2, Issue 2, 2023, Pages 6-12]
  • Antiviral effect Antibacterial, antiviral, and antifungal activities of quinine and its derivatives: A narrative mini-review [Volume 2, Issue 3, 2023, Pages 1-6]
  • Apoptosis Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms [Volume 2, Issue 1, 2023, Pages 1-7]
  • Apoptosis Novel formulations of hesperidin for antitumor, antimicrobial, and neuroprotective effects: A review [Volume 2, Issue 2, 2023, Pages 13-19]
  • Apoptosis Therapeutic activities of the main bioactive compounds via modulating sirtuins: A review [Volume 3, Issue 1, 2024, Pages 1-7]
  • Artificial intelligence Are clinical trials complex projects? [Volume 2, Issue 3, 2023, Pages 13-23]
  • Atropine Anticholinergic, antimicrobial, and anticancer perspectives of atropine: a mini-review [Volume 2, Issue 1, 2023, Pages 39-44]

B

  • Bacterial Cellulose Anticancer, antibacterial, antiviral, and antifungal applications of cellulose and its derivatives: Novel formulations [Volume 3, Issue 1, 2024, Pages 29-34]
  • Bacterial infections A review on antifungal and antibacterial activities of some medicinal plants [Volume 1, Issue 1, 2022, Pages 10-17]
  • Bacterial nanocellulose Anticancer, antibacterial, antiviral, and antifungal applications of cellulose and its derivatives: Novel formulations [Volume 3, Issue 1, 2024, Pages 29-34]
  • BDNF Effects of curcuminoids and resveratrol in micro and nanoformulations on brain-derived neurotrophic factor: A brief review [Volume 2, Issue 4, 2023, Pages 35-40]
  • Behavioral intervention Are clinical trials complex projects? [Volume 2, Issue 3, 2023, Pages 13-23]
  • Binding energy Docking of the main protein receptors of SARS-CoV-2 by hesperidin metabolite: In silico study [Volume 2, Issue 3, 2023, Pages 24-31]
  • Biocompatibility Interaction of copper oxide nanoparticles with bacterial nucleic acids: a mini-review [Volume 2, Issue 1, 2023, Pages 20-25]
  • Biocompatible biopolymer Antibacterial, antifungal, antiviral, and anticancer activities of chitosan and its derivatives: Basic mechanisms [Volume 3, Issue 1, 2024, Pages 23-28]
  • Biodegradable carriers Novel formulations of alginate and its derivatives in microbial infections, biomedical implants, and cancers [Volume 3, Issue 1, 2024, Pages 35-40]
  • Biodegradable nanomaterials Effects of curcuminoids and resveratrol in micro and nanoformulations on brain-derived neurotrophic factor: A brief review [Volume 2, Issue 4, 2023, Pages 35-40]
  • Biological instability Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Biological macromolecules Antibacterial, antifungal, antiviral, and anticancer activities of chitosan and its derivatives: Basic mechanisms [Volume 3, Issue 1, 2024, Pages 23-28]
  • Biomedicine Are clinical trials complex projects? [Volume 2, Issue 3, 2023, Pages 13-23]
  • Bisdemethoxycurcumin Anticancer, antimicrobial, anti-inflammatory, and neuroprotective effects of bisdemethoxycurcumin: Micro and nano facets [Volume 2, Issue 4, 2023, Pages 17-24]
  • Black tea Docking of helicase, main protease, papain-like protease, and RNA-dependent RNA polymerase of SARS-CoV-2 by theaflavin-3-gallate [Volume 2, Issue 3, 2023, Pages 38-44]
  • Blood-Brain Barrier Effects of quercetin on the hippocampal proteins of BDNF, CREB, DCX, FOXG1, GDNF, and synapsin II: The potential molecular mechanisms [Volume 3, Issue 1, 2024, Pages 8-13]
  • Brevibacillus centrosporus Larvicidal activities of local bacteria against Aedes aegypti larvae [Volume 2, Issue 2, 2023, Pages 34-41]

C

  • Carbon nanotubes Oncogenic and anticancer roles of miRNAs in colorectal cancer: A review [Volume 3, Issue 1, 2024, Pages 14-22]
  • Catechins Micro and nanoformulations of catechins for therapeutic applications: recent advances and challenges [Volume 2, Issue 1, 2023, Pages 8-19]
  • CB-Dock Docking of the main protein receptors of SARS-CoV-2 by hesperidin metabolite: In silico study [Volume 2, Issue 3, 2023, Pages 24-31]
  • Cellular processes Therapeutic activities of the main bioactive compounds via modulating sirtuins: A review [Volume 3, Issue 1, 2024, Pages 1-7]
  • Chitin deacetylation Antibacterial, antifungal, antiviral, and anticancer activities of chitosan and its derivatives: Basic mechanisms [Volume 3, Issue 1, 2024, Pages 23-28]
  • Cisplatin Formulations of galangin and its derivatives with antimicrobial, anticancer, and anti-neurodegenerative effects: Recent advances and challenges [Volume 2, Issue 4, 2023, Pages 41-46]
  • Clinical stages Are clinical trials complex projects? [Volume 2, Issue 3, 2023, Pages 13-23]
  • Co-clinical trials Are clinical trials complex projects? [Volume 2, Issue 3, 2023, Pages 13-23]
  • Cognitive Function Lutein with various therapeutic activities based on micro and nanoformulations: A systematic mini-review [Volume 2, Issue 4, 2023, Pages 1-7]
  • Cognitive performance Antioxidant, antineurodegenerative, anticancer, and antimicrobial activities of caffeine and its derivatives: micro and nano aspects [Volume 2, Issue 3, 2023, Pages 32-37]
  • Combination therapy Therapeutic potentials of reserpine formulations: Recent progress and challenges [Volume 2, Issue 2, 2023, Pages 1-5]
  • Cosmeceutical nanogels Antioxidant, antineurodegenerative, anticancer, and antimicrobial activities of caffeine and its derivatives: micro and nano aspects [Volume 2, Issue 3, 2023, Pages 32-37]
  • Cosmeceutical products Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Curcuminoids Anticancer, antimicrobial, anti-inflammatory, and neuroprotective effects of bisdemethoxycurcumin: Micro and nano facets [Volume 2, Issue 4, 2023, Pages 17-24]
  • Curcuminoids Curcumin and their derivatives with anti-inflammatory, neuroprotective, anticancer, and antimicrobial activities: A review [Volume 2, Issue 4, 2023, Pages 25-34]
  • Cytobacillus firmus Larvicidal activities of local bacteria against Aedes aegypti larvae [Volume 2, Issue 2, 2023, Pages 34-41]

D

  • Dendrimers Oncogenic and anticancer roles of miRNAs in colorectal cancer: A review [Volume 3, Issue 1, 2024, Pages 14-22]
  • Deoxyribonucleic Acid Interaction of copper oxide nanoparticles with bacterial nucleic acids: a mini-review [Volume 2, Issue 1, 2023, Pages 20-25]
  • Detergent Removal Conventional and novel methods for the preparation of micro and nanoliposomes [Volume 1, Issue 1, 2022, Pages 18-29]
  • DNA ladder formation Therapeutic potentials of reserpine formulations: Recent progress and challenges [Volume 2, Issue 2, 2023, Pages 1-5]
  • DNA Repair Novel formulations of hesperidin for antitumor, antimicrobial, and neuroprotective effects: A review [Volume 2, Issue 2, 2023, Pages 13-19]
  • Drug Delivery Main distinctions between tocosome and nano-liposome as drug delivery systems: A scientific and technical point of view [Volume 2, Issue 1, 2023, Pages 26-29]
  • Drug delivery systems Micro and nano formulas of phyto-drugs naringenin and naringin with antineoplastic activity: Cellular and molecular aspects [Volume 2, Issue 2, 2023, Pages 27-33]
  • Drug loading efficiency Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Drug resistance Various novel strategies for functionalization of gold and silver nanoparticles to hinder drug-resistant bacteria and cancer cells [Volume 1, Issue 1, 2022, Pages 38-48]
  • Drug-resistant bacteria The role of ACT and FOX genes in Klebsiella pneumoniae strains isolated from hospitalized patients [Volume 1, Issue 2, 2022, Pages 18-25]

E

  • Effective formulations Anticholinergic, antimicrobial, and anticancer perspectives of atropine: a mini-review [Volume 2, Issue 1, 2023, Pages 39-44]
  • Efficient learning Lutein with various therapeutic activities based on micro and nanoformulations: A systematic mini-review [Volume 2, Issue 4, 2023, Pages 1-7]
  • Efflux Pump Anticancer and antibacterial activities of embelin: Micro and nano aspects [Volume 1, Issue 1, 2022, Pages 30-37]
  • Encapsulation Main distinctions between tocosome and nano-liposome as drug delivery systems: A scientific and technical point of view [Volume 2, Issue 1, 2023, Pages 26-29]
  • Encapsulation Therapeutic potentials of reserpine formulations: Recent progress and challenges [Volume 2, Issue 2, 2023, Pages 1-5]
  • Endophytes A review on antifungal and antibacterial activities of some medicinal plants [Volume 1, Issue 1, 2022, Pages 10-17]
  • Ergogenic aid Antioxidant, antineurodegenerative, anticancer, and antimicrobial activities of caffeine and its derivatives: micro and nano aspects [Volume 2, Issue 3, 2023, Pages 32-37]
  • Escherichia fergusonii Larvicidal activities of local bacteria against Aedes aegypti larvae [Volume 2, Issue 2, 2023, Pages 34-41]
  • Extended-Spectrum Beta-Lactamases Relationship between MOX genes and antibiotic resistance in Klebsiella pneumoniae strains in nosocomial infections [Volume 1, Issue 2, 2022, Pages 12-17]
  • Eye health Lutein with various therapeutic activities based on micro and nanoformulations: A systematic mini-review [Volume 2, Issue 4, 2023, Pages 1-7]

F

  • Flavanoglycone Novel formulations of hesperidin for antitumor, antimicrobial, and neuroprotective effects: A review [Volume 2, Issue 2, 2023, Pages 13-19]
  • Flavanone glycoside Novel formulations of hesperidin for antitumor, antimicrobial, and neuroprotective effects: A review [Volume 2, Issue 2, 2023, Pages 13-19]
  • Flavonol Formulations of galangin and its derivatives with antimicrobial, anticancer, and anti-neurodegenerative effects: Recent advances and challenges [Volume 2, Issue 4, 2023, Pages 41-46]
  • Fungal infections A review on antifungal and antibacterial activities of some medicinal plants [Volume 1, Issue 1, 2022, Pages 10-17]

G

  • Gastrointestinal barriers Formulations of galangin and its derivatives with antimicrobial, anticancer, and anti-neurodegenerative effects: Recent advances and challenges [Volume 2, Issue 4, 2023, Pages 41-46]
  • Genetics factors Oncogenic and anticancer roles of miRNAs in colorectal cancer: A review [Volume 3, Issue 1, 2024, Pages 14-22]
  • Gold Nanoparticles Various novel strategies for functionalization of gold and silver nanoparticles to hinder drug-resistant bacteria and cancer cells [Volume 1, Issue 1, 2022, Pages 38-48]

H

  • Helicase NSP13 Docking of helicase, main protease, papain-like protease, and RNA-dependent RNA polymerase of SARS-CoV-2 by theaflavin-3-gallate [Volume 2, Issue 3, 2023, Pages 38-44]
  • Herbal cellulose Anticancer, antibacterial, antiviral, and antifungal applications of cellulose and its derivatives: Novel formulations [Volume 3, Issue 1, 2024, Pages 29-34]
  • Hippocampal Novel formulations of hesperidin for antitumor, antimicrobial, and neuroprotective effects: A review [Volume 2, Issue 2, 2023, Pages 13-19]
  • Hippocampal neurogenesis Effects of quercetin on the hippocampal proteins of BDNF, CREB, DCX, FOXG1, GDNF, and synapsin II: The potential molecular mechanisms [Volume 3, Issue 1, 2024, Pages 8-13]
  • Hippocampal proteins Effects of quercetin on the hippocampal proteins of BDNF, CREB, DCX, FOXG1, GDNF, and synapsin II: The potential molecular mechanisms [Volume 3, Issue 1, 2024, Pages 8-13]
  • Hospital isolates of K. pneumoniae The role of ACT and FOX genes in Klebsiella pneumoniae strains isolated from hospitalized patients [Volume 1, Issue 2, 2022, Pages 18-25]
  • Hospitalized Patients Relationship between MOX genes and antibiotic resistance in Klebsiella pneumoniae strains in nosocomial infections [Volume 1, Issue 2, 2022, Pages 12-17]
  • Hospitalized Patients The role of ACT and FOX genes in Klebsiella pneumoniae strains isolated from hospitalized patients [Volume 1, Issue 2, 2022, Pages 18-25]
  • Hydrophobic polymers Novel formulations of alginate and its derivatives in microbial infections, biomedical implants, and cancers [Volume 3, Issue 1, 2024, Pages 35-40]
  • Hypertension Therapeutic potentials of reserpine formulations: Recent progress and challenges [Volume 2, Issue 2, 2023, Pages 1-5]

I

  • Industrial applications Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Infectious Diseases Interaction of copper oxide nanoparticles with bacterial nucleic acids: a mini-review [Volume 2, Issue 1, 2023, Pages 20-25]
  • Inflammation Therapeutic activities of the main bioactive compounds via modulating sirtuins: A review [Volume 3, Issue 1, 2024, Pages 1-7]
  • Intra-abdominal infections Relationship between MOX genes and antibiotic resistance in Klebsiella pneumoniae strains in nosocomial infections [Volume 1, Issue 2, 2022, Pages 12-17]
  • Isoflavon Therapeutic aspects of genistein based on recent advances and challenges [Volume 2, Issue 2, 2023, Pages 6-12]

K

  • Kaempferol-3-glucoside Novel formulations of Kaempferol and its monosaccharide derivatives for healing cancers and microbial infections [Volume 2, Issue 3, 2023, Pages 7-12]
  • Kaempferol 7-O-glucoside Novel formulations of Kaempferol and its monosaccharide derivatives for healing cancers and microbial infections [Volume 2, Issue 3, 2023, Pages 7-12]

L

  • Larvicidal potential Larvicidal activities of local bacteria against Aedes aegypti larvae [Volume 2, Issue 2, 2023, Pages 34-41]
  • Lipid-based nanocarrier Antioxidant, antineurodegenerative, anticancer, and antimicrobial activities of caffeine and its derivatives: micro and nano aspects [Volume 2, Issue 3, 2023, Pages 32-37]
  • Liposome Main distinctions between tocosome and nano-liposome as drug delivery systems: A scientific and technical point of view [Volume 2, Issue 1, 2023, Pages 26-29]
  • Lower bioavailability Therapeutic applications of apigenin and its derivatives: micro and nano aspects [Volume 2, Issue 1, 2023, Pages 30-38]

M

  • Medical intervention Are clinical trials complex projects? [Volume 2, Issue 3, 2023, Pages 13-23]
  • Membrane permeability Antibacterial, antifungal, antiviral, and anticancer activities of chitosan and its derivatives: Basic mechanisms [Volume 3, Issue 1, 2024, Pages 23-28]
  • Metabolic diseases Therapeutic activities of the main bioactive compounds via modulating sirtuins: A review [Volume 3, Issue 1, 2024, Pages 1-7]
  • Micro and nanosystems Micro and nanoformulations of catechins for therapeutic applications: recent advances and challenges [Volume 2, Issue 1, 2023, Pages 8-19]
  • Micro aspects Therapeutic applications of apigenin and its derivatives: micro and nano aspects [Volume 2, Issue 1, 2023, Pages 30-38]
  • Microcrystalline cellulose Anticancer, antibacterial, antiviral, and antifungal applications of cellulose and its derivatives: Novel formulations [Volume 3, Issue 1, 2024, Pages 29-34]
  • Microfluidic Systems Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Micro RNA-200a Lutein with various therapeutic activities based on micro and nanoformulations: A systematic mini-review [Volume 2, Issue 4, 2023, Pages 1-7]
  • MiR-145 Oncogenic and anticancer roles of miRNAs in colorectal cancer: A review [Volume 3, Issue 1, 2024, Pages 14-22]
  • Mitogen-activated protein kinases Formulations of galangin and its derivatives with antimicrobial, anticancer, and anti-neurodegenerative effects: Recent advances and challenges [Volume 2, Issue 4, 2023, Pages 41-46]
  • Monodipserse liposomes Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Multiple Sclerosis Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms [Volume 2, Issue 1, 2023, Pages 1-7]

N

  • Nano aspects Therapeutic applications of apigenin and its derivatives: micro and nano aspects [Volume 2, Issue 1, 2023, Pages 30-38]
  • Nanocarriers Theranostic safe quantum dots for anticancer and bioimaging applications [Volume 1, Issue 2, 2022, Pages 1-11]
  • Nanocarriers Novel formulations of Kaempferol and its monosaccharide derivatives for healing cancers and microbial infections [Volume 2, Issue 3, 2023, Pages 7-12]
  • Nanocarriers Curcumin and their derivatives with anti-inflammatory, neuroprotective, anticancer, and antimicrobial activities: A review [Volume 2, Issue 4, 2023, Pages 25-34]
  • Nanocrystalline cellulose Anticancer, antibacterial, antiviral, and antifungal applications of cellulose and its derivatives: Novel formulations [Volume 3, Issue 1, 2024, Pages 29-34]
  • Nanoencapsulation Lutein with various therapeutic activities based on micro and nanoformulations: A systematic mini-review [Volume 2, Issue 4, 2023, Pages 1-7]
  • Nanofibrillated cellulose Anticancer, antibacterial, antiviral, and antifungal applications of cellulose and its derivatives: Novel formulations [Volume 3, Issue 1, 2024, Pages 29-34]
  • Nanoformulation Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms [Volume 2, Issue 1, 2023, Pages 1-7]
  • Nanoformulations Anticancer, antimicrobial, anti-inflammatory, and neuroprotective effects of bisdemethoxycurcumin: Micro and nano facets [Volume 2, Issue 4, 2023, Pages 17-24]
  • Nanogels Novel formulations of alginate and its derivatives in microbial infections, biomedical implants, and cancers [Volume 3, Issue 1, 2024, Pages 35-40]
  • Nanoliposome Conventional and novel methods for the preparation of micro and nanoliposomes [Volume 1, Issue 1, 2022, Pages 18-29]
  • Nanoliposome Main distinctions between tocosome and nano-liposome as drug delivery systems: A scientific and technical point of view [Volume 2, Issue 1, 2023, Pages 26-29]
  • Nanomaterials Synergistic combinations of metal, metal oxide, or metalloid nanoparticles plus antibiotics against resistant and non-resistant bacteria [Volume 1, Issue 1, 2022, Pages 1-9]
  • Nanomaterials Formulations of galangin and its derivatives with antimicrobial, anticancer, and anti-neurodegenerative effects: Recent advances and challenges [Volume 2, Issue 4, 2023, Pages 41-46]
  • Nanotechnology Synergistic combinations of metal, metal oxide, or metalloid nanoparticles plus antibiotics against resistant and non-resistant bacteria [Volume 1, Issue 1, 2022, Pages 1-9]
  • Naringenin Micro and nano formulas of phyto-drugs naringenin and naringin with antineoplastic activity: Cellular and molecular aspects [Volume 2, Issue 2, 2023, Pages 27-33]
  • Neurodegenerative Diseases Micro and nanoformulations of catechins for therapeutic applications: recent advances and challenges [Volume 2, Issue 1, 2023, Pages 8-19]
  • Neurodegenerative Diseases Effects of curcuminoids and resveratrol in micro and nanoformulations on brain-derived neurotrophic factor: A brief review [Volume 2, Issue 4, 2023, Pages 35-40]
  • Neurodegenerative Diseases Effects of quercetin on the hippocampal proteins of BDNF, CREB, DCX, FOXG1, GDNF, and synapsin II: The potential molecular mechanisms [Volume 3, Issue 1, 2024, Pages 8-13]
  • Neuroprotective Therapeutic aspects of genistein based on recent advances and challenges [Volume 2, Issue 2, 2023, Pages 6-12]
  • Neuroprotective activity Therapeutic applications of apigenin and its derivatives: micro and nano aspects [Volume 2, Issue 1, 2023, Pages 30-38]
  • Neurotrophin proteins Effects of curcuminoids and resveratrol in micro and nanoformulations on brain-derived neurotrophic factor: A brief review [Volume 2, Issue 4, 2023, Pages 35-40]
  • Niosomes Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Nosocomial infections Relationship between MOX genes and antibiotic resistance in Klebsiella pneumoniae strains in nosocomial infections [Volume 1, Issue 2, 2022, Pages 12-17]

O

  • Oolong tea Docking of helicase, main protease, papain-like protease, and RNA-dependent RNA polymerase of SARS-CoV-2 by theaflavin-3-gallate [Volume 2, Issue 3, 2023, Pages 38-44]
  • Organic nanomaterials Antioxidant, antineurodegenerative, anticancer, and antimicrobial activities of caffeine and its derivatives: micro and nano aspects [Volume 2, Issue 3, 2023, Pages 32-37]
  • Organic nanomaterials Curcumin and their derivatives with anti-inflammatory, neuroprotective, anticancer, and antimicrobial activities: A review [Volume 2, Issue 4, 2023, Pages 25-34]

P

  • Parkinson's disease Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms [Volume 2, Issue 1, 2023, Pages 1-7]
  • Pathogenic bacteria Synergistic combinations of metal, metal oxide, or metalloid nanoparticles plus antibiotics against resistant and non-resistant bacteria [Volume 1, Issue 1, 2022, Pages 1-9]
  • Phenotypic diagnosis The role of ACT and FOX genes in Klebsiella pneumoniae strains isolated from hospitalized patients [Volume 1, Issue 2, 2022, Pages 18-25]
  • Photoluminescence Theranostic safe quantum dots for anticancer and bioimaging applications [Volume 1, Issue 2, 2022, Pages 1-11]
  • Plant-derived metabolite Novel formulations of Kaempferol and its monosaccharide derivatives for healing cancers and microbial infections [Volume 2, Issue 3, 2023, Pages 7-12]
  • Plasmodium falciparum Antibacterial, antiviral, and antifungal activities of quinine and its derivatives: A narrative mini-review [Volume 2, Issue 3, 2023, Pages 1-6]
  • Pneumonia infections Relationship between MOX genes and antibiotic resistance in Klebsiella pneumoniae strains in nosocomial infections [Volume 1, Issue 2, 2022, Pages 12-17]
  • Preclinical application Micro and nano formulas of phyto-drugs naringenin and naringin with antineoplastic activity: Cellular and molecular aspects [Volume 2, Issue 2, 2023, Pages 27-33]
  • Prosthetic implants Micro and nanoformulations of catechins for therapeutic applications: recent advances and challenges [Volume 2, Issue 1, 2023, Pages 8-19]
  • Proto alkaloids Anticholinergic, antimicrobial, and anticancer perspectives of atropine: a mini-review [Volume 2, Issue 1, 2023, Pages 39-44]
  • Psychoactive drug Antioxidant, antineurodegenerative, anticancer, and antimicrobial activities of caffeine and its derivatives: micro and nano aspects [Volume 2, Issue 3, 2023, Pages 32-37]

Q

  • Quantum dots Theranostic safe quantum dots for anticancer and bioimaging applications [Volume 1, Issue 2, 2022, Pages 1-11]
  • Quinine derivatives Antibacterial, antiviral, and antifungal activities of quinine and its derivatives: A narrative mini-review [Volume 2, Issue 3, 2023, Pages 1-6]
  • Quinine sulfate Antibacterial, antiviral, and antifungal activities of quinine and its derivatives: A narrative mini-review [Volume 2, Issue 3, 2023, Pages 1-6]

R

  • Rauwolfia alkaloids Therapeutic potentials of reserpine formulations: Recent progress and challenges [Volume 2, Issue 2, 2023, Pages 1-5]
  • Ribonucleic acid Interaction of copper oxide nanoparticles with bacterial nucleic acids: a mini-review [Volume 2, Issue 1, 2023, Pages 20-25]

S

  • SARS-CoV-2 helicase Docking of the main protein receptors of SARS-CoV-2 by hesperidin metabolite: In silico study [Volume 2, Issue 3, 2023, Pages 24-31]
  • Semi-organic nanomaterials Curcumin and their derivatives with anti-inflammatory, neuroprotective, anticancer, and antimicrobial activities: A review [Volume 2, Issue 4, 2023, Pages 25-34]
  • Side Effects Medicinal perspectives of colchicine and its derivatives: recent progress and challenges [Volume 2, Issue 2, 2023, Pages 20-26]
  • Signaling proteins Therapeutic activities of the main bioactive compounds via modulating sirtuins: A review [Volume 3, Issue 1, 2024, Pages 1-7]
  • Silver nanoparticles Various novel strategies for functionalization of gold and silver nanoparticles to hinder drug-resistant bacteria and cancer cells [Volume 1, Issue 1, 2022, Pages 38-48]
  • Sirtuin expression Therapeutic activities of the main bioactive compounds via modulating sirtuins: A review [Volume 3, Issue 1, 2024, Pages 1-7]
  • Supramolecular assembly Industrial-scale methods for the manufacture of liposomes and nanoliposomes: pharmaceutical, cosmetic, and nutraceutical aspects [Volume 1, Issue 2, 2022, Pages 26-35]
  • Synergistic Effects Synergistic combinations of metal, metal oxide, or metalloid nanoparticles plus antibiotics against resistant and non-resistant bacteria [Volume 1, Issue 1, 2022, Pages 1-9]

T

  • Theaflavin 3 Anti-neurodegenerative, anticancer, anti-inflammatory, and antiobesity activities of theaflavin and its derivatives [Volume 2, Issue 4, 2023, Pages 8-16]
  • Theaflavin 3-gallate Anti-neurodegenerative, anticancer, anti-inflammatory, and antiobesity activities of theaflavin and its derivatives [Volume 2, Issue 4, 2023, Pages 8-16]
  • Theaflavin-3-gallate Docking of helicase, main protease, papain-like protease, and RNA-dependent RNA polymerase of SARS-CoV-2 by theaflavin-3-gallate [Volume 2, Issue 3, 2023, Pages 38-44]
  • Theaflavin 3′ -gallate Anti-neurodegenerative, anticancer, anti-inflammatory, and antiobesity activities of theaflavin and its derivatives [Volume 2, Issue 4, 2023, Pages 8-16]
  • Therapeutic limitation Novel formulations of Kaempferol and its monosaccharide derivatives for healing cancers and microbial infections [Volume 2, Issue 3, 2023, Pages 7-12]
  • Therapeutic options Relationship between MOX genes and antibiotic resistance in Klebsiella pneumoniae strains in nosocomial infections [Volume 1, Issue 2, 2022, Pages 12-17]
  • Therapeutic strategies Interaction of copper oxide nanoparticles with bacterial nucleic acids: a mini-review [Volume 2, Issue 1, 2023, Pages 20-25]
  • Thin film hydration Conventional and novel methods for the preparation of micro and nanoliposomes [Volume 1, Issue 1, 2022, Pages 18-29]
  • Tissue engineering Micro and nanoformulations of catechins for therapeutic applications: recent advances and challenges [Volume 2, Issue 1, 2023, Pages 8-19]
  • Tocosome Main distinctions between tocosome and nano-liposome as drug delivery systems: A scientific and technical point of view [Volume 2, Issue 1, 2023, Pages 26-29]
  • TrkB signaling pathway Effects of curcuminoids and resveratrol in micro and nanoformulations on brain-derived neurotrophic factor: A brief review [Volume 2, Issue 4, 2023, Pages 35-40]
  • Tropane ring Anticholinergic, antimicrobial, and anticancer perspectives of atropine: a mini-review [Volume 2, Issue 1, 2023, Pages 39-44]
  • True alkaloids Anticholinergic, antimicrobial, and anticancer perspectives of atropine: a mini-review [Volume 2, Issue 1, 2023, Pages 39-44]
  • Turmeric Anticancer, antimicrobial, anti-inflammatory, and neuroprotective effects of bisdemethoxycurcumin: Micro and nano facets [Volume 2, Issue 4, 2023, Pages 17-24]

V

  • Viral replication Docking of the main protein receptors of SARS-CoV-2 by hesperidin metabolite: In silico study [Volume 2, Issue 3, 2023, Pages 24-31]
  • Virulence factors Docking of the main protein receptors of SARS-CoV-2 by hesperidin metabolite: In silico study [Volume 2, Issue 3, 2023, Pages 24-31]